Among U.S. Veterans, risk was lower for supplemented Black veterans and those with 0 to 19 ng/mL vitamin D serum levels
THURSDAY, Feb. 2, 2023 (HealthDay News) — Supplementation with vitamin D is associated with a reduced risk for suicide and intentional self-harm among U.S. Veterans, according to a study published online Feb. 1 in PLOS ONE.
Jill E. Lavigne, Ph.D., M.P.H., and Jason B. Gibbons, from the Center of Excellence for Suicide Prevention in Canandaigua, New York, conducted a retrospective cohort study of U.S. Veterans supplemented with vitamin D to examine the association with suicide attempts and intentional self-harm. Veterans with any vitamin D3 or vitamin D2 fill between 2010 and 2018 were matched to untreated control veterans in a 1:1 ratio.
The researchers found that vitamin D3 and vitamin D2 supplementation was associated with a reduced risk for suicide and self-harm (hazard ratios, 0.552 and 0.512 for vitamin D3 and vitamin D2, respectively). Compared with controls, supplemented Black veterans and veterans with 0 to 19 ng/mL vitamin D serum levels had a significantly lower risk (hazard ratios, 0.362 and 0.359, respectively). Greater risk reductions were seen for supplementation with higher vitamin D doses than lower doses (log average dosage hazard ratio, 0.837).
“As a relatively safe, easily accessible, and affordable medication, supplementation with vitamin D in the VA may hold promise if confirmed in clinical trials to prevent suicide attempts and suicide,” the authors write.
Higher Parental Vitamin B12 Tied to Lower Prevalence of Birth Defects
Children, Teens Have Higher Psychological Burden of Atopic Dermatitis
High-Dose Intravenous Vitamin C May Benefit Trauma Patients
Vitamin A, D May Aid Asthma Outcomes
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children
Fractional Exhaled Nitric Oxide Elevated in Pediatric Chest Tightness Variant Asthma
Higher Short-Term Exposure to Pollen Linked to Lower FEV1 in COPD
Higher Diet Quality Linked to Improved Lung Function in Asthma, COPD